Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams

Infectious Disease Clinics of North America

Volumn 11, Issue 4, 1997, Pages 875-887

  Jacoby, G A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; MEROPENEM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CITROBACTER; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; PLASMID; PROTEUS; REVIEW; SALMONELLA; SERRATIA MARCESCENS;

EID: 0031438322     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70395-0     Document Type: Article

References (48)

1. R.P. Ambler A.F.W. Coulson Frère J.-M. A standard numbering scheme for the class A beta-lactamases Biochem J 276 1991 269
2. G. Arlet M. Rouveau I. Casin Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals J Clin Microbiol 32 1994 2553
3. A. Bauernfeind Y. Chong S. Schweighart Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins Infection 17 1989 316
4. A. Bauernfeind I. Stemplinger R. Jungwirth Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases Antimicrob Agents Chemother 40 1996 509
5. P.A. Bradford C. Urban A. Jaiswal SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients Antimicrob Agents Chemother 39 1995 899
6. P.A. Bradford C. Urban N. Mariano Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein Antimicrob Agents Chemother 41 1997 563
7. C. Brun-Buisson P. Legrand A. Philippon Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae Lancet ii 1987 302
8. D.R. Burwen S.N. Banerjee R.P. Gaynes Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States J Infect Dis 170 1994 1622
9. K. Bush S.B. Singer Biochemical characteristics of extended broad spectrum β-lactamases Infection 17 1989 429
10. M.G. Cormican S.A. Marshall R.N. Jones Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen J Clin Microbiol 34 1996 1880
11. De Champs C. D. Rouby D. Guelon A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1(TEM-3) beta-lactamase J Hosp Infect 18 1991 5
12. De Champs C. M.P. Sauvant C. Chanal Prospective survey of colonization and infection caused by expanded-spectrum-β-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit J Clin Microbiol 27 1989 2887
13. G.L. French K.P. Shannon N. Simmons Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase J Clin Microbiol 34 1996 358
14. Hibberd PL, Jacoby GA: Multiply drug resistant Klebsiella pneumoniae (MDRKP) strains; predictors of acquisition and mortality [abstract C46]. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 1994, p 87.
15. G.S. Itokazu J.P. Quinn C. Bell-Dixon Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program Clin Infect Dis 23 1996 779
16. Jacoby G, Bush K: Amino acid sequences for TEM, SHV and OXA extended-spectrum β-lactamases. http://www.lahey.hitchcock.org/pages/1hc/studies/webt.htm
17. G.A. Jacoby The genetics of extended-spectrum beta-lactamases Eur J Clin Microbiol Infect Dis 13 Suppl 1 1994 2
18. Jacoby GA: Characteristics of an outbreak of multidrug resistant Klebsiella pneumoniae (MDRKP) infections [abstract C48]. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando 1994, p 88.
19. G.A. Jacoby I. Carreras Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases Antimicrob Agents Chemother 34 1990 858
20. G.A. Jacoby P. Han Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli J Clin Microbiol 34 1996 908
21. Jacoby GA, Han P, Alvarez M, et al: Survey of extended-spectrum β-lactamase (ESBL) production in US clinical isolates [abstract C40]. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco 1995, p 46.
22. G.A. Jacoby A.A. Medeiros More extended-spectrum β-lactamases Antimicrob Agents Chemother 35 1991 1697
23. G.A. Jacoby L. Sutton Properties of plasmids responsible for extended-spectrum β-lactamase production Antimicrob Agents Chemother 35 1991 164
24. Jarlier V. Nicolas M.-H. G. Fournier Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns Rev Infect Dis 10 1988 867
25. J.A. Karas D.G. Pillay D. Muckart Treatment failure due to extended spectrum β-lactamase J Antimicrob Chemother 37 1996 203
26. Lucet J.-C. S. Chevret D. Decré Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition Clin Infect Dis 22 1996 430
27. L. Martínez-Martínez S. Hernández-Allés S. Albertí In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins Antimicrob Agents Chemother 40 1996 342
28. A. Medeiros Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics Clin Infect Dis 24 Suppl 1 1997 S19
29. K.S. Meyer C. Urban J.A. Eagan Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins Ann Intern Med 119 1993 353
30. J.Z. Montgomerie Epidemiology of Klebsiella and hospital-associated infections Rev Infect Dis 1 1979 736
31. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th ed. Approved standard M2-A6 1997 National Committee for Clinical Laboratory Standards Villanova, PA
32. L. Naumovski J.P. Quinn D. Miyashiro Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients Antimicrob Agents Chemother 36 1992 1991
33. M.T. Nüesch-Inderbinen H. Hächler F.H. Kayser Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test Eur J Clin Microbiol Infect Dis 15 1996 398
34. B. Pangon C. Bizet A. Buré In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase J Infect Dis 159 1989 1005
35. G.A. Papanicolaou A.A. Medeiros G.A. Jacoby Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae Antimicrob Agents Chemother 34 1990 2200
36. A. Philippon R. Labia G. Jacoby Extended-spectrum β-lactamases Antimicrob Agents Chemother 33 1989 1131
37. B.A. Rasmussen P.A. Bradford J.P. Quinn Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 β-lactamases encoded by different nucleotide sequences Antimicrob Agents Chemother 37 1993 1989
38. L.B. Rice L.L. Carias R.A. Bonomo Molecular genetics of resistance to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy J Infect Dis 173 1996 151
39. L.B. Rice L.L. Carias D.M. Shlaes In vivo efficacies of β-lactam-β-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae Antimicrob Agents Chemother 38 1994 2663
40. L.B. Rice E.C. Eckstein J. DeVente Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center Clin Infect Dis 23 1996 118
41. L.B. Rice S.H. Marshall L.L. Carias Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum β-lactamase genes Antimicrob Agents Chemother 37 1993 2760
42. L.B. Rice S.H. Willey G.A. Papanicolaou Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility Antimicrob Agents Chemother 34 1990 2193
43. C.C. Sanders A.L. Barry J.A. Washington Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test J Clin Microbiol 34 1996 2997
44. D.A. Schiappa M.K. Hayden M.G. Matushek Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case control and molecular epidemiologic investigation J Infect Dis 174 1996 529
45. IMP) in gram-negative rods resistant to broad-spectrum β-lactams J Clin Microbiol 34 1996 2909
46. D.L. Sirot F.W. Goldstein C.J. Soussy Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae : a 3-year survey in France Antimicrob Agents Chemother 36 1992 1677
47. Swenson JM, Ferraro MJ, Jorgensen JH, et al: Can different breakpoints be used to detect extended-spectrum β-lactamase (ESBL)-producing organisms? [abstract D22]. In Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996, p 64.
48. C. Urban K.S. Meyer N. Mariano Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae Antimicrob Agents Chemother 38 1994 392